Home Community The VTA Meets The FDA to Discusses The Imminent Synthetic Nicotine Ban

Community

The VTA Meets The FDA to Discusses The Imminent Synthetic Nicotine Ban

After a ban on synthetic nicotine was passed last month, the Vapor Trade Association (VTA) set up a meeting with the Food and Drug Administration (FDA) to present the scientific evidence indicting the public health benefits of endorsing products containing synthetic nicotine.

Diane Caruana

April 19, 2022

The VTA held presentations in order to frame critical scientific and public policy issues that we believe had not previously been presented to or considered by the FDA.

A new bill recently signed into law by Congress, will ban any vaping products containing synthetic nicotine. The substance had so far been manufactured and sold legally across the US.

After the passing of the synthetic nicotine ban, the VTA immediately began working on a strategy to ensure a viable path for companies which are selling the products. Meanwhile, the VTA’s Board of Directors and members met with the FDA Center for Tobacco Products (CTP) to discuss the ban.

The FDA personnel in attendance included over 35 senior leaders, representing seven different offices inside CTP. The VTA held presentations by three Ph.D’s in Organic Chemistry and Physical Analytical Chemistry, in order to frame critical scientific and public policy issues that we believe had not previously been presented to or considered by the FDA.

Coalition sends letter to Califf

Meanwhile, the new FDA Commissioner Robert M. Califf M.D., has just received a letter in opposition to the ban. The groups are also urging Commissioner Califf to allow small businesses trying to comply with the new restriction, to remain on the market for longer than the 60 stipulated days as they prepare their marketing applications.